TP53 and neoplasm: Over the past 15 years such results have spurred a number of studies aimed at developing the means for restoring wild type p53 function in cells including viral delivery of p53 cDNAs and the rational design of small molecules or peptides that can stimulate p53 functions or reactivate tumor-associated mutant p53 proteins [13], [14], [15].